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Abstract
Acid‐sensing ion channels (ASICs) are proton‐gated channels involved in multiple 
biological functions such as: pain modulation, mechanosensation, neurotransmis-
sion, and neurodegeneration. Earlier, we described the genetic association, within the 
Nuoro population, between Multiple Sclerosis (MS) and rs28936, located in ASIC2 
3′UTR. Here we investigated the potential involvement of ASIC2 in MS inflamma-
tory process. We induced experimental autoimmune encephalomyelitis (EAE) in 
wild‐type (WT), knockout Asic1−/− and Asic2−/− mice and observed a significant 
reduction of clinical score in Asic1−/− mice and a significant reduction in the clinical 
score in Asic2−/− mice in a limited time window (i.e., at days 20–23 after immuniza-
tion). Immunohistochemistry confirmed the reduction in adaptive immune cell infil-
trates in the spinal cord of EAE Asic1−/− mice. Analysis of mechanical allodynia, 
showed a significant higher pain threshold in Asic2−/− mice under physiological con-
ditions, before immunization, as compared to WT mice and Asic1−/−. A significant 
reduction in pain threshold was observed in all three strains of mice after immuniza-
tion. More importantly, analysis of human autoptic brain tissue in MS and control 
samples showed an increase of ASIC2 mRNA in MS samples. Subsequently, in vitro 
luciferase reporter gene assays, showed that ASIC2 expression is under possible 
miRNA regulation, in a rs28936 allele‐specific manner. Taken together, these find-
ings suggest a potential role of ASIC2 in the pathophysiology of MS.
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1 |  INTRODUCTION
Over the last decade, genetic research on multiple sclerosis 
(MS) has led to the discovery of more than 100 non‐MHC 
(Major Histocompatibility Complex) susceptibility vari-
ants, which play an important role in both the innate and 
the adaptive immune system, with a prominent representa-
tion of the latter (Beecham et al., 2013; Consortium et al., 
2011; Dendrou, Fugger, & Friese, 2015; Lill et al., 2015; 
Moutsianas et al., 2015; Patsopoulos et al., 2011). Genes 
driving the Central Nervous System's (CNS) intrinsic in-
flammatory arm still deserve close examination in order to 
clarify the mechanisms of axonal degeneration in MS and the 
genetic contributions to disease severity or subphenotypes 
(Hoppenbrouwers & Hintzen, 2011).
We focused our study on ASIC2, an interesting candidate 
gene widely expressed in the brain.
The idea of focusing on this gene came from the discov-
ery, during our previous work on the isolated population of 
the Nuoro province (Sardinia, Italy), of a significant asso-
ciation between MS and (a) the microsatellite D17S798 in 
the 17q11.2 region, a marker close to ASIC2 and (b) the 
3′UTR single nucleotide polymorphism (SNP) rs28936 
(Bernardinelli et al., 2007). Additional interest on ASIC2 
was provided by a genetic study on mice with experimen-
tal autoimmune encephalomyelitis (EAE), a mouse model of 
MS (Jagodic et al., 2004), where strong evidence of linkage 
in correspondence of the Eae18b QTL was found; in partic-
ular, ASIC2 is the closest gene to the peak linkage marker 
D10Rat123.
ASIC2 encodes the mammalian degenerin (MDEG) 
protein and in the nematode Caenorhabditis Elegans 
mutations of MDEG homologues known as degenerins 
(deg‐1, mec‐4, mec‐10) are involved in neurodegeneration 
(Waldmann, Champigny, Voilley, Lauritzen, & Lazdunski, 
1996). ASIC2 is a member of the ASIC (acid sensing ion 
channel) family. From four different genes (ASIC1, ASIC2, 
ASIC3, and ASIC4), 6 subunits have been reported so far: 
ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3, and ASIC4 to 
form proton‐dependent ion channels that are mainly per-
meable to sodium. Among them, ASIC1a and ASIC2a are 
highly expressed in the CNS, where they interact to form 
functional homotrimeric or heterotrimeric complexes, with 
variable stoichiometric ratios (2:1 or 1:2), different sen-
sitivity to pH, and unique biophysical properties (Bartoi, 
Augustinowski, Polleichtner, Gründer, & Ulbrich, 2014; 
Wu, Xu, et al., 2016). ASIC2a is less sensitive to pH 
changes with respect to ASIC1a, ASIC1b and ASIC3, al-
though its sensitivity changes when it heteromultimerizes 
with other subunits. ASIC1a homomers and ASIC1a‐
ASIC2b heteromers also show, in addition to Na+, a per-
meability for Ca2+ (Ortega‐Ramírez, Vega, & Soto, 2017) 
and an excessive accumulation of these ions is known to 
be involved in neurodegeration and inflammation in MS 
(Friese et al., 2007). ASIC1a is the key subunit determin-
ing acid‐activated current in CNS, thus playing a critical 
role in neurological and psychological diseases; while 
ASIC2a play important modulatory roles in acid‐induced 
responses (Wu, Leng, et al., 2016). ASIC2b is not sensitive 
to acid and does not form functional homomeric channels, 
but it contributes to proton‐sensing by forming heteromeric 
channels with other ASIC subunits (Zhou et al., 2016). In 
mice, ASIC1 and ASIC2 subunits often colocalize in mul-
tiple brain regions, despite the differences observed in cer-
tain brain areas (Price et al., 2014).
Our interest in this class of genes, and in particular on 
ASIC2, was further motivated by literature evidence show-
ing that ASIC channels are involved in multiple biological 
functions such as: pain modulation, mechanosensation, aci-
dosis‐induced neuronal death and neurotransmission (Kang 
et al., 2012; Kweon & Suh, 2013; Ortega‐Ramírez et al., 
2017; Sherwood, Lee, Gormley, & Askwith, 2011; Wemmie, 
Taugher, & Kreple, 2013). ASICs are activated in response 
to extracellular acidification occurring in neurotransmission 
at synaptic level (reviewed in Boscardin, Alijevic, Hummler, 
Frateschi, & Kellenberger, 2016). Most recently, ASICs have 
been involved in regulating synaptic plasticity in the amyg-
dala (Du et al., 2014) and the generation of postsynaptic 
currents by ASIC1a and ASIC2 was reported to act on the 
reduction of cocaine addiction (Kreple et al., 2014). They 
also play an important role in detecting the local pH changes 
induced by inflammation‐associated processes (Radu et al., 
2014; Rajamäki et al., 2013). Importantly, ASICs have been 
linked to immunological function, due to their ability of en-
hancing antigen presentation of dendritic cells (Tong et al., 
2011). Evidence of ASICs involvement in axonal degenera-
tion firstly came from a study performed in EAE mice car-
rying two copies of a genetically inactivated ASIC1 gene 
(Asic1−/−) (Friese et al., 2007). This study also showed that 
a hypoxia‐induced dysfunction in mitochondrial metabolism 
evokes acidosis in the neuronal tissue of the EAE‐induced 
mice, which activates ASIC1. Subsequent studies performed 
on both acute and chronic EAE models demonstrated that 
ASIC1 upregulation and function play an important role in 
the axonal and myelin damage in acute and chronic‐relaps-
ing EAE, while blocking ASIC1 with amiloride exerted a 
neuro‐ and also myelo‐protective effect in both acute and 
chronic EAE (Vergo et al., 2011). In autoptic brain tissues 
from patients affected by Primary Progressive MS (PPMS) 
upregulation of ASIC1 was also observed, and amiloride ad-
ministration improved tissue lesions in PPMS thus exerting 
a neuroprotective effect, as indicated in a pilot trial (Arun 
et al., 2013). Converging statistical and biological evidences 
implicate ASICs as putative MS susceptibility genes and the 
investigation of their role in MS has just begun (Zhou et al., 
2016). Despite the fact that most studies cited above were 
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focused on ASIC1, it is reasonable to hypothesize that ASIC2 
could also play an important role in MS pathogenesis, as the 
two channels interact. Our research aimed at filling this gap 
by investigating the possible involvement of ASIC2 in MS 
inflammatory and neurodegenerative processes, via different 
experimental in vivo and in vitro approaches. A further aim 
was to replicate the results obtained for ASIC1 by a previous 
study in EAE mice (Friese et al., 2007) and to interpret them 
jointly with those obtained for ASIC2.
2 |  MATERIAL AND METHODS
2.1 | Workflow of the study
The initial idea of this study came after finding evidence of a 
statistically significant association, obtained in our previous 
study on Sardinian families, between the ASIC2 3′UTR vari-
ant rs28936, located in a miRNA‐binding site, and MS.
Despite our research primarily is focuded on ASIC2, we 
also tried to replicate the experiments, mostly obtained by 
Friese et al. (2007), on EAE mice showing a strong involve-
ment of ASIC1 gene on neurodegeneration.
This logic led us to plan the following experiments:
a Analyze clinical scores and pain thresholds in wild‐type 
(WT) and Asic2−/− mice with induced EAE, in different 
phases of the disease;
b Perform histology and immunohistochemistry of cerebel-
lum and spinal cord in WT and Asic2−/− mice;
c Study ASIC2 gene expression on post‐mortem brain tissue 
of MS patients and controls;
d Investigate the role of rs28936 as a possible miRNA‐bind-
ing site.
e Perform the same experiment as (a) and (b) on Asic1−/− 
mice for sake of replication of the published previous 
results.
2.2 | ASICs involvement in EAE
All experimental procedures on animals were performed in 
accordance with the Italian (D.L. 26/2014) and European 
Union Directive (2010/63/EU) on the protection of animals 
used for scientific purposes. Experiments were approved 
by the Italian Ministry of Health. All efforts were made to 
minimize the number of animals used and to alleviate their 
discomfort.
Wild‐type, Asic1−/− and Asic2−/− male mice (kindly pro-
vided by Dr. Margaret Price, University of Iowa, Iowa City, IA, 
USA) at 6/7 weeks of age were used. All mice were obtained 
by homozygous breeding. Mice were kept under environmen-
tally controlled conditions (ambient temperature, 22°C; hu-
midity, 40%) on a 12‐hr light/dark cycle with food and water 
ad libitum. EAE, a T cell‐dependent mouse model of MS 
that recapitulates many of the clinical and neuropathological 
modifications observed in the human disease, was induced 
in WT (n = 14), Asic1−/− (n = 10) and Asic2−/− (n = 14) 
mice by subcutaneous (s.c.) immunization with 200 μg of 
MOG35‐55 peptide (MEVGWYRSPFSRVVHLYRNGK – 
Genemed Synthesis, San Antonio, TX, USA) emulsified in 
0.1 ml of incomplete Freund's adjuvant (Sigma‐Aldrich, St. 
Louis, MO, USA) containing 2 mg of Mycobacterium tuber-
culosis strain H37Ra (Difco Laboratories, Detroit, MI, USA). 
200 ng of pertussis toxin (Calbiochem, La Jolla, CA, USA) 
dissolved in 200 μl phosphate‐buffered saline were injected 
intraperitoneally on the day of immunization and 48 hrs later. 
Mice were weighted and monitored daily for 40 days and neu-
rological signs were scored according to the following scale: 
0 = no symptoms; 1 = limp tail; 2 = partial paralysis of hind 
limbs; 3 = complete paralysis of hind limbs or partial hind 
and front limb paralysis; 4 = tetraparalysis; 5 = moribund/
death. Forty‐five days after MOG immunization, mice were 
killed and spinal cords were dissected out for histological and 
immunohistochemical examination.
The experiments were performed by an unbiased method 
carried out by expert experimenter unaware of the mouse 
genotype. Statistical analysis was performed by a Two‐way 
ANOVA Repeated Measures + Bonferroni post hoc test. To 
evaluate the existence of a statistically significant difference 
in the pattern of clinical score in WT vs Asic1−/− and WT vs 
Asic2−/− in the 40 days after immunization, we also calcu-
lated for each time point the difference in the mean of the ob-
served clinical scores between WT and Asic1−/− and WT and 
Asic2−/−. To perform a statistical test of the null hypothesis 
of no difference between the means of the mice groups being 
compared, we simulated 100,000 samples under the null hy-
pothesis and we plotted the 90% non‐parametric confidence 
intervals (CIs) by identifying the interval including 90% of 
the samples, in the empirical distribution of the simulated val-
ues. This approach takes into account the correlation between 
clinical scores observed in the same mouse at different days 
after immunization. We computed a 90% CI (i.e., 5% one‐tail 
test) since our a priori expectation is that the lack of ASIC2/
ASIC1 gene implicates an improvement of the clinical score 
in comparison to that observed in WT. We tested the hypoth-
esis that the difference between Asic2−/−/Asic1−/− and WT 
profiles is significantly different from zero and negative. Data 
points lying outside the lower confidence band can be inter-
preted as evidence of a departure from the null hypothesis.
2.3 | Histology and immunohistochemistry 
analysis of spinal cord of EAE mice
Mice were killed by decapitation after administration of a light 
anesthesia with isoflurane and histological analysis and im-
munohistochemistry were performed as previously reported 
(Fallarino et al., 2010) on three mice for each experimental 
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group representative of WT, Asic1−/− and Asic2−/− mice with 
induced EAE. Thirty μm sections of the spinal cord were 
stained by hematoxylin/eosin to reveal CNS inflammatory in-
filtrates. For immunohistochemical analysis, 30 μm sections 
were soaked in 3% hydrogen peroxide to block endogenous 
peroxidase activity and then stained with rat monoclonal anti‐
CD4 (1:500; ab64144, Abcam, Cambridge, UK), mouse mon-
oclonal anti‐class II MHC (1:500; MAB 2221, Chemicon, 
Tecumela, CA, USA) or rat monoclonal anti‐CD8 (1:100; 
NBP1‐49045, Novus Biologicals, Littleton, CO, USA) fol-
lowed by appropriate biotinylated secondary antibodies (anti‐
mouse, 1:200; BA2000 or anti‐rat, 1:200; BA4000, Vector 
Laboratories, Burlingame, CA, USA) and streptavidin‐HRP 
(Zymed, Waltham, MA, USA). For the quantification of the 
inflammation in the spinal cord white matter, the percentage 
of white matter infiltrated by CD4+, CD8+, and MHCII cells 
in transverse spinal cord sections of three EAE mice was 
determined by acquiring images at 10X and analyzing with 
the Image J software. Data were analyzed by using one‐way 
ANOVA + Fisher's least significant difference (LSD).
2.4 | Assessment of mechanical allodynia 
in mice
Mechanical pain thresholds were quantified in WT (n = 20), 
Asic1−/− (n = 12) and Asic2−/− (n = 21) mice under basal 
conditions (prior immunization), and at 28 and 40 days after 
immunization, by measuring the hind paw withdrawal re-
sponse to von Frey filament stimulation. Mice were placed in 
a Plexiglas box (20 cm high, 9 cm diameter) with a wire grid 
bottom through which the von Frey filaments (North Coast 
Medical, Inc., San Jose, CA, USA), bending force range from 
0.008 to 3.5 g, were applied by using a modified version of the 
up‐down paradigm, as previously reported (Chaplan, Bach, 
Pogrel, Chung, & Yaksh, 1994). The filaments were applied 
five times each and pressed perpendicularly to the plantar 
surface of both right‐ and left‐hind paws until they bent. The 
first filament, which evoked at least three responses, was as-
signed blindly as the pain threshold in grams. The experi-
ments were performed by an unbiased method carried out by 
expert experimenter unaware of the mouse genotype. Data 
were analyzed by using one‐way ANOVA + Fisher's LSD.
2.5 | Quantification of ASIC2 expression in 
autoptic human brain tissues
ASIC2 expression was quantified in 62 cases with secondary 
progressive MS and 32 controls (affected by other non‐neuro-
logical diseases) in brain tissues from different brain regions 
including occipital, frontal, parietal and temporal lobes, cer-
ebellum, thalamus and hippocampus. Human tissue samples 
were kindly provided by the Multiple Sclerosis Society Tissue 
Bank of the Imperial College, London (Burlington Danes, 160 
Du Cane Road, London W12; www.ukmstissuebank.imperial.
ac.uk). For four samples, one of the two measurements were 
missing; we imputed these missing values via multivariate im-
putation by chained equation (MICE R package; van Buuren 
& Groothuis‐Oudshoorn, 2011). The whole 3′UTR region 
(chr17:31,340,123‐31,340,982 – GRCh37/hg19) containing 
the marker rs28936 was fully genotyped by Next Generation 
Sequencing (NGS). Briefly, the region of interest was am-
plified in each sample by PCR reaction, using the couple of 
primers (Forward – TCTTAACCTGCCCAAAAACC and 
Reverse – GGGAGAGAAGAACGACATGG). PCR reaction 
was performed in a total volume of 25 μl containing 50 ng 
genomic DNA, 5 pmol of each primer, 1 × Taq polymerase 
buffer (1.5 mm MgCl2) and 0.5 units of Red Taq (Sigma).
The PCR amplification was carried out for 35 cycles 
(denaturation at 94°C for 45 s, annealing for 1 min at 55°C, 
extension at 72°C for 45 s and final extension for 10 min at 
72°C). Libraries for NGS analysis were obtained from PCR 
amplicons by NGS Illumina NEXTERA XT assay and fol-
lowing the procedures indicated by the vendor. Libraries 
were finally analyzed with Illumina Miseq sequencer. 
Bioinformatics analysis was performed by the software 
Miseq reporter in order to obtain for each sample analysed 
a list of Genomic variants in a VCF format file. Genotyping 
data about rs28936 have been extracted from VCF files and 
recorded in a pedigree format files.
Total RNA from human brain samples was extracted using 
Trizol reagent (Invitrogen, Carlsbad, CA, USA) accord-
ing to manufacturer's protocol. The RNA was treated with 
DNAse (Qiagen, Hilden, Germany) and single strand cDNA 
was synthesized from 2 μg of total RNA using superscript 
III (Invitrogen) and random hexamers. Real‐time PCR was 
performed on 20 ng of cDNA by using specific primers and 
Power SYBR Green Master Mix (Applied Biosystem, Foster 
City, CA) on an Applied Biosystems Step‐One instrument. 
Thermal cycler conditions were: 10 min at 95°C, 40 cycles of 
denaturation (15 s at 95°C), and combined annealing/exten-
sion (1 min at 60°C).
Primers used were as follows: ASIC2 Forward 
TGAGTGCCGATCCTCAGAGA and Reverse TGTAGCG 
GGTTAGGTTGCAG and GAPDH Forward TTGCCATCAA 
TGACCCCTTCA and Reverse CGCCCCACTTGATTTT 
GGA. Here, mRNA copy number of ASIC2 gene was cal-
culated from serially diluted standard curves simultaneously 
amplified with the samples and normalized against GAPDH 
copy number. Two technical replicates were run for each 
PCR reaction. P < 0.05 at Student's t test was considered 
significant.
2.6 | Luciferase reporter gene assay
In order to investigate whether ASIC2 expression is under 
miRNAs regulation dependent on rs28936 genotype, we 
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performed a luciferase reporter gene assay. ASIC2 3′UTR 
was cloned from two different genotypes (rs28936A and 
rs28936G) downstream of the firefly luciferase gene in the 
dual‐luciferase plasmid pmirGLO (Promega) and the two 
constructs were sequenced to confirm the correct inser-
tion of the fragments. We transfected both constructs into 
MCF7 cells (TCC‐HTB‐22) in the presence or absence of a 
siRNA that targets Dicer or a non‐specific siRNA (negative 
control). The cells were cultured in a 96‐well plate start-
ing at a density of 4 × 104 cells/cm2. We then compared 
the effect of Dicer siRNA on luciferase activity derived 
from the two constructs using the Dual‐Glo Luciferase 
Assay System (Promega) according to the manufacturer's 
description.
The Dicer siRNA (s23755 by ThermoFisher Scientific) 
is not directed against ASIC2 3′UTR, however, it is ex-
pected to down‐regulate the accumulation of all miRNAs 
since Dicer is required for the biogenesis of all miR-
NAs. Therefore, if the 3′UTR of the gene is targeted by 
any miRNA, in the absence of Dicer, we would observe a 
higher luciferase activity.
Each assay was repeated eight times (two independent 
experiments with four biological replicates each) and the 
firefly luciferase activity was normalized for the Renilla 
luciferase activity for each assay. Given the limited number 
of observations and the impossibility to verify the normal-
ity assumption, we analyzed data using a non‐parametric 
Wilcoxon rank sum test. The test was one‐sided, based on 
F I G U R E  1  (a) Clinical score of mice after immunization with MOG35‐55 peptide. Values are means + SEM and data are cumulative of 
two independent experiments with similar results with a total of 14 wild‐type (WT), 10 Asic1−/− and 14 Asic2−/− mice. * p = 0.019 (strain 
factor); p < 0.001 (time factor); p < 0.001 (strain × time factor) vs. WT mice; # p = 0.013 for day 20; p = 0.004 for day 21; p = 0.013 for day 22; 
p = 0.032 for day 23 of WT mice vs. the respective values in Asic2−/− mice (Two‐way ANOVA Repeated Measures + Bonferroni post hoc test). 
(b) Comparison between the observed difference between the mean clinical scores of Asic2−/− and wild‐type (WT) and the pattern of difference 
simulated under the null hypothesis of no difference. (c) Comparison between the observed difference between the mean clinical scores of Asic1−/− 
and wild‐type (WT) and the pattern of difference simulated under the null hypothesis of no difference. In (b) and (c) data points lying outside the 
lower confidence band can be interpreted as evidence of a departure from the null hypothesis of no difference
(a)
(b) (c)
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the a priori hypothesis that miRNA binding to the target 
sequence is expected to decrease gene expression, and 
hence luciferase activity.
3 |  RESULTS
3.1 | ASICs involvement in EAE
In order to study whether ASIC1 and ASIC2 have a dis-
ease‐modifying effect, thus suggesting an involvement in the 
pathogenesis of MS, we induced EAE on mice. MOG‐im-
munized WT mice showed a mean onset of the disease on 
day 16.7 ± 1, reached the peak of the clinical score on day 
22 (cumulative score = 50.2 ± 4.3) with an incidence of 
100%. Asic1−/− mice showed a mean onset of the disease on 
day 23 + 1.9, reached the peak of the clinical score on day 
28 (cumulative score = 35.5 + 4.8) with an incidence of 90%. 
Asic2−/− mice showed a mean onset of the disease on day 
20.8 + 2.2, reached the peak of the clinical score on day 37 
(cumulative score = 40.1 + 6.1) with an incidence of 100%. 
Analysis of the clinical score in the three strains of mice 
showed that Asic1−/− mice have a delayed disease onset and 
EAE peak, in line with the scientific literature (Friese et al., 
2007), whereas Asic2−/− mice showed a significant reduction 
of the clinical score only in days 20–23 after immunization 
(Figure 1a). To test if there was a significant difference be-
tween the profiles of the three strains of mice we computed 
the 90% empirical CIs. The latter were computed from the 
empirical distribution generated by permutation under the 
null hypothesis of no difference between the mean of clinical 
score of Asic1−/− and WT and between the mean of clinical 
score of Asic2−/− and WT. Data points lying outside the lower 
F I G U R E  2  Histopathological analysis of spinal cord in EAE mice. (a) Representative spinal cord sections from wild‐type (WT), Asic1−/−, 
and Asic2−/− mice at 45 days after immunization. Sections of the spinal cord anterior horn were stained with hematoxylin and eosin (E&H) 
to assess inflammation and immunostained for MCHII, CD4+, CD8+ infiltrating cells. (b) Graphs show the quantification of the extent of 
inflammation and infiltrating MCHII, CD4+ and CD8+ cells in the anterior horn of the spinal cord. Values are means + SEM (n = 3 animals for 
each group). *p = 0.014 for CD4+ cells/mm2 vs. WT mice; ** p = 0.008 for CD4+ cells/mm2 vs. WT mice; p < 0.001 for % white matter with 
CD4+ immunoreactivity vs. WT mice; p < 0.001 for CD8+ cells/mm2 vs. WT mice; p < 0.001 for % white matter with CD8+ immunoreactivity 
vs. WT mice; p = 0.091 for MHCII cells/mm2 vs. WT mice; p < 0.002 for % white matter with MHCII immunoreactivity vs. WT mice (One‐way 
ANOVA + Fisher's LSD)
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confidence band can be interpreted as evidence of a departure 
from the null hypothesis. We observed a series of consecutive 
data points lying below the lower band of 90% CI (Figure 1b 
and c). This pattern was much more pronounced for Asic1−/− 
than for Asic2−/−. More specifically, in Asic1−/− mice, the 
clinical score showed a statistically significant reduction from 
day 14 to day 24 since EAE induction; for Asic2−/− the reduc-
tion is still statistically significant but from 20 to 23 days and 
the size of the reduction is a much less than for Asic1−/− mice.
3.2 | Histology and immunohistochemistry 
analysis of spinal cord of EAE mice
Wild‐type mice immunized with MOG35‐55 showed adap-
tive immune cell infiltrates in the spinal cord, assessed at 
day 45 following immunization (Figure 2a). CD4+ and MHC 
class‐II+ mononuclear cells were largely predominant in the 
immune infiltrate, although CD8+ cytotoxic cells could also 
be detected. Quantification of the adaptive immune cell in-
filtrates in the spinal cord showed a significant reduction in 
Asic1−/− mice which paralleled the reduced clinical score of 
EAE mice (Figure 2b). We observed an increase of CD4+ 
mononuclear cells in Asic2−/− mice when the clinical score 
was similar to WT mice (Figure 2b).
3.3 | ASICs involvement in pain
To assess the involvement of ASIC1 and ASIC2 in pain and if 
EAE induction promotes any differential change, we measured 
mechanical pain thresholds in WT, Asic1−/− and Asic2−/− mice 
under basal physiological conditions and in pathological con-
ditions at 28 and 40 days after immunization. It is noteworthy 
under physiological conditions, i.e., before immunization, in 
Asic2−/−, we observed a significant increased mechanical pain 
threshold as compared to Asic1−/− and WT mice (Figure 3). 
After immunization, WT and Asic1−/− mice showed a reduced 
mechanical pain threshold by about 4–5 fold, but, to our sur-
prise, Asic2−/− mice also showed a reduced mechanical pain 
threshold by about 6 fold, likely due to the partial paralysis 
of posterior legs that may have occluded the increased pain 
threshold observed before EAE in these mice.
3.4 | ASIC2 mRNA expression is increased 
in MS brain
ASIC2 expression was quantified in human brain tissues of 62 
cases with secondary progressive MS and 32 controls (affected 
by other non‐neurological disease). Quantitative real‐time 
PCR analysis showed a significant increase of ASIC2 tran-
script in brain tissues of MS cases compared to control cases 
(Figure 4), suggesting a role of ASIC2 in the pathophysiology 
of MS, while we did not observe evidence of a significant ef-
fect of rs28936 genotype under the assumption of a recessive 
model, on ASIC2 expression level possibly due to the small 
sample size (p = 0.11, β = −22.14 [−49.53; 5.24]).
We also analyzed the association between rs28936 and 
MS in brain samples (β = 1.02 [−0.02; 2.21], p = 0.068). 
This borderline significance is probably due to the small 
sample size.
Rs28936 was analyzed, assuming a genetic recessive 
model (only AA genotype will increase disease risk), after 
testing for the departure from the additive model. p < 0.05 
on 2‐sided test was considered as statistically significant. The 
means ± SEM of the expression data of the subject carried, 
respectively, the AA genotype and the GA/GG genotypes are 
62.5 ± 5.19 and 79.2 ± 5.70.
3.5 | ASIC2 3′UTR regulation is 
Dicer dependent
Next, we performed a luciferase report gene assay to investi-
gate whether ASIC2 expression is under miRNAs regulation 
F I G U R E  3  Mechanical allodynia assessment in mice. 
Mechanical pain thresholds were assessed in wild‐type (WT; 
n = 20), Asic1−/− (n = 12) and Asic2−/− (n = 21) mice under basal 
physiological conditions (before immunization), and in pathological 
conditions at 28 days and at 40 days after immunization with 
MOG35‐55 peptide. Values are means ± SEM and are cumulative of two 
independent experiments. * p < 0.001 vs. WT and Asic1−/− mice under 
basal conditions (before immunization), and # p = 0.007 WT mice at 
28 days vs. WT mice before immunization; p = 0.025 Asic1−/− mice 
at 28 days vs. Asic1−/− mice before immunization; p < 0.001 Asic2−/− 
mice at 28 days vs. Asic2−/− mice before immunization; p = 0.016 WT 
mice at 40 days vs. WT mice before immunization; p < 0.001 Asic2−/− 
mice at 40 days vs. Asic2−/− mice before immunization (One‐way 
ANOVA + Fisher's LSD)
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dependent on rs28936 genotype. All the results are presented 
in Table 1.
We found that the rs28936A construct showed a higher 
increase in luciferase activity than the rs28936G construct in 
the presence of Dicer siRNA (p = 3.51 × 10−7). The increase 
represents the difference between activity in the presence of 
the Dicer siRNA and scrambled siRNA.
This indicates that rs28936A ASIC2 mRNA is under 
stronger miRNA regulation than rs28936G, as luciferase 
activity is more increased when the global miRNA level is 
lower. However, the rs28936G is also under a milder con-
trol, with an increase of luciferase activity which is statisti-
cally different from zero (p = 7.42 × 10−5), suggesting that 
both rs28936 alleles are under the control of microRNAs.
4 |  DISCUSSION
The genetic association between rs28936 in the 3′UTR of 
ASIC2 and MS observed in Nuoro population (Bernardinelli 
et al., 2007), the evidence that ASIC1 is involved in the 
pathogenesis of EAE on animal model (Friese et al., 2007) 
and the altered expression of sodium channels reported in 
MS (Waxman, 2001) lead us to hypothesize that ASIC2, with 
which ASIC1 interacts forming heteromultimeric channels, 
could be an important contributor to neuropathological pro-
cesses in MS.
Although ASIC2 subunits are widely expressed in brain 
and modulate ASIC1a current, their function is not yet 
clear. To investigate our hypothesis of an involvement of 
ASIC2 in MS, we carried out different experiments, both 
in vivo and in vitro. In the first in vivo experiment we an-
alysed clinical scores in WT, Asic2−/− and Asic1−/− mice 
with induced EAE at different times from immunization. 
As expected, after induction of EAE, mice lacking Asic1 
showed an attenuation of the clinical score over time com-
pared to WT. These effects were also observed in Asic2−/− 
mice but in a limited time window. Immunohistochemistry 
for MHCII, CD4+ and CD8+ on spinal cord of EAE mice 
showed a significant reduction of inflammatory infiltrates 
in ASIC1−/− mice paralleling the clinical score. An increase 
of CD4+ mononuclear cells was observed in Asic2−/− mice, 
whereas MHCII and CD8+ were not modified as compared 
to WT mice. We do not have any explanation for this ef-
fect. Overall, these results suggest that despite the fact that 
ASIC1 seems to play a major role in EAE severity, ASIC2 
is also involved, probably as a consequence of the physical 
interaction existing between the two channels.
The pH changes in inflamed tissue led to hypothesize that 
local acidosis may be involved in pain and given the involve-
ment of ASICs in pain modulation (Wemmie et al., 2013), 
we analyzed mechanical pain thresholds in WT, Asic2−/− and 
Asic1−/− mice under physiological conditions, i.e., before im-
munization, and at different time points after immunization. 
We observed an increased pain threshold in Asic2−/− mice in 
physiological conditions, as compared to Asic1−/− and WT. 
Our results are in line with the observation that Asic1−/− mice 
do not show alteration of skin mechanoreceptor function in 
physiological conditions (Page et al., 2004) and are in con-
trast with data reported by others (Price et al., 2000; Roza 
et al., 2004; Staniland & McMahon, 2009). In this latter case 
the authors obtained data from an in vitro skin/nerve prepa-
ration (Price et al., 2000; Roza et al., 2004), which is a dif-
ferent condition than the more complex in vivo situation. The 
observations that triple knockout mice for Asic1a, Asic2 and 
Asic3, in physiological conditions, have an increased pain 
sensitivity (Kang et al., 2012), and the lack of increased pain 
F I G U R E  4  ASIC2 mRNA levels in the brain of 32 control cases 
and 62 multiple sclerosis (MS) cases. Single values are shown along 
with means ± SEM expressed as % to cumulate data coming from 
different quantitative PCR runs. * p = 0.0457 (Student')s t test)
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T A B L E  1  Luciferase reporter gene assay results
AA construct, Dicer 
siRNA Median (IQR)
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Wilcoxon rank‐sum test. Descriptive measures are median and interquartile range.
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threshold in Asic2−/− mice (Staniland & McMahon, 2009), 
which contrasts with our results, may suggest complex inter-
actions between these three cation channels and other pro-
teins in modulating pain transmission. In fact, ASICs interact 
with multiple scaffolding proteins, as PSD‐95 (Zha et al., 
2009) and ion channels linked to mechanosensation, as Big 
Potassium channels (Petroff et al., 2008). We observed a sta-
tistically significant reduction of mechanical pain thresholds 
in all strains of mice after EAE. However, other models of 
acute and chronic inflammatory pain and neuropathic pain 
may help to understand the role of ASICs in pain processing 
and pain matrix.
Our investigation on the role of ASIC2 and rs28936, 
with regard to an allelic‐specific expression, led us to ana-
lyze the transcript of this gene in autopsy brains of MS cases 
and controls. The quantitative analysis showed an increased 
expression of ASIC2 in MS brains, but we found only a 
weak statistical evidence of rs28936 allele‐specific effect 
(p = 0.11), possibly due to a lack of power.
Given that ASIC1a activation triggers the intracellular ac-
cumulation of Na+ and Ca2+ involved in neurodegenerative 
and inflammatory processes typical of MS, an overexpres-
sion of ASIC2 in MS brain could facilitate the heteromulti-
merization of ASIC2 subunits with ASIC1a; thus, resulting 
in an increase of channel expression at the cell surface and 
consequently of acid‐evoked current. When ASIC2a hetero-
multimerizes with other subunits, it reduces pH sensitivity. 
Furthermore, ASIC2 subunits facilitate subcellular localiza-
tion of ASIC channels (Harding, Kusama, Hattori, Gautam, 
& Benson, 2014) through the interaction between ASIC2 
and the neuronal scaffolding protein PSD‐95, thus increasing 
ASIC1a localization in dendritic spines (Zha et al., 2009).
Luciferase report assay on MCF7 cells showed a higher 
increase in luciferase activity for rs28936A than rs28926G in 
the presence of Dicer siRNA compared to scrambled siRNA 
treatment, highlighting that rs28936A is under a stronger 
miRNA regulation.
The impact of miRNAs regulation in MS has started to 
emerge in the last few years, and a few miRNAs have been 
found differentially expressed in MS lesions. An interest-
ing example is represented by hsa‐miR‐27a, whose expres-
sion was found upregulated in active MS lesions (Junker 
et al., 2009). Hsa‐miR‐27a is induced in response to hypoxia 
(Camps et al., 2014), which is a well‐known feature of in-
flammation leading to acidosis, which in turn opens ASICs 
channels. We hence may hypothesized that the induction of 
this miRNA in presence of acidosis could decrease the ex-
pression of ASIC2 and it may results in a lower response to 
acidosis and inflammation, thus exerting a possible protec-
tive effect.
In conclusion, the strength of our study stands in the use 
of complementary approaches (in vivo, in vitro, and human 
brain samples) to characterize ASIC2 contribution in MS 
pathophysiology and the integration of different evidences 
from experimental data on the role of ASIC2 in MS, which 
was previously limited to ASIC1. The significant reduc-
tion of the clinical score in Asic2−/− mice in a limited time 
window, and, more importantly, the increased expression 
of ASIC2 in human brain MS samples, despite some lim-
itations, suggests a possible role of ASIC2 in the patho-
physiology of MS even if additional studies are required to 
firmly establish it.
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